Tobacco giant Philip Morris International (PMI) has bought a 22.61 percent stake in British asthma inhaler maker Vectura. Following the deal, PMI announced that it plans to continue acquiring Vectura shares on the market at 165p (RUB167) per share. informs CNBC.
PMI is interested in Vectura, as it believes that in the future, the acquisition of the company will allow it to earn more. The cigarette maker is counting on the absorption of Vectura, intending increase their revenues from the sale of goods and services not related to nicotine, up to a billion dollars a year. It is assumed that PMI will gain access to inhaler technologies for the production of alternative smoking systems, however, the production of the asthma drugs Vectura will continue after the takeover.
Read Also
- This router with WiFi 6 makes the most of your connection, and now it costs only 34 euros in the Huawei store | Technology May 31, 2021
- Why WhatsApp is being used by companies to have more customers May 31, 2022
- Damaged car, what is convenient and not worth repairing Jul 8, 2021
- Sonego with Alcaraz, but the rain stops everything. It is also up to Berrettini and Fognini Aug 17, 2021
- Kimberly Loaiza revealed if she is pregnant for the third time May 29, 2022
- Google has created an original Doodle Day embroidered May 21, 2020
- A Russian missile was about to hit the main atomic plant in southern Ukraine: “It is an act of nuclear terrorism” Jun 5, 2022